Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Illumina Inc
(NQ:
ILMN
)
108.35
+0.74 (+0.69%)
Streaming Delayed Price
Updated: 12:05 PM EDT, May 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Illumina Inc
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
CNBC's Final Trades: iShares MSCI UK, Illumina, US Silica And This Company That Has An Attractive Buyout Deal
February 27, 2022
On CNBC’s “Halftime Report...
Via
Benzinga
Bionano Stock Looks to Have a Monster Comeback in Its Future
February 17, 2022
Bionano's Saphyr appears to be able to help doctors treat leukemia, and the adoption of its device is growing rapidly.
Via
InvestorPlace
Give peace a chance
February 15, 2022
Israeli fabless semiconductor maker Tower was bought by Intel for $5.4 bn today.
Via
Talk Markets
Barron's Latest Picks And Pans: Zillow, Coca Cola, Illumina, Spotify And More
February 12, 2022
This weekend's Barron's cover story says there will be a dramatic increase in betting on this year's Super Bowl, a trend that's likely to continue for years to...
Via
Benzinga
Dominion Energy, Under Armour, And Expedia Among Another Slew Of Earnings Reports
February 11, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. (Friday Market Open) Equity index...
Via
Benzinga
Illumina's Q4 Profit Falls Despite Topline Growth Of 26%
February 11, 2022
Illumina Inc (NASDAQ: ILMN) reported
Via
Benzinga
Earnings Scheduled For February 10, 2022
February 10, 2022
Companies Reporting Before The Bell • Canada Goose Hldgs (NYSE:GOOS) is projected to report quarterly earnings at $1.46 per share on revenue of $584.49 million.
Via
Benzinga
Expert Ratings For Illumina
February 11, 2022
Over the past 3 months, 5 analysts have published their opinion on Illumina (NASDAQ:ILMN) stock. These analysts are typically employed by large Wall Street banks and tasked with...
Via
Benzinga
The Daily Biotech Pulse: Adcom Recommends Additional Trials For Lilly's Partnered Cancer Drug, Novavax Touts Pediatric Vaccine Data, TC Biopharm IPO
February 11, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adcom Rules That Lilly May Have To Conduct Additional Studies For Co-...
Via
Benzinga
10 Biggest Price Target Changes For Friday
February 11, 2022
SVB Leerink cut Illumina, Inc. (NASDAQ: ILMN) price target from $430 to $400. Illumina shares fell 0.7% to $355.70 in pre-market trading.
Via
Benzinga
A Peek Into The Markets: US Stock Futures Down Following Thursday's Plunge
February 11, 2022
Pre-open movers U.S. stock futures traded lower in early pre-market trade after the Dow Jones tumbled more than 500 points in the previous session. Investors are awaiting earnings...
Via
Benzinga
Analyst Ratings For Illumina
January 11, 2022
Within the last quarter, Illumina (NASDAQ:ILMN) has observed the following ...
Via
Benzinga
5 Stocks To Watch For February 11, 2022
February 11, 2022
Some of the stocks that may grab investor focus today are:
Via
Benzinga
Illumina: Q4 Earnings Insights
February 10, 2022
Illumina (NASDAQ:ILMN) reported its Q4 earnings results on Thursday, February 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Illumina beat estimated earnings...
Via
Benzinga
The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly
February 10, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
How Far Can the Stock Market Fall?
February 05, 2022
The stock market as measured by the S&P 500 has been correcting since the start of the new year. Most of the damage has come from the significantly overvalued constituents.
Via
Talk Markets
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
February 06, 2022
Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big...
Via
Benzinga
Panic reversal
January 26, 2022
Crude oil inventories turned out to be fuller than expected, helping reduce the oil price rise.
Via
Talk Markets
Stocks That Hit 52-Week Lows On Wednesday
January 26, 2022
During Wednesday's morning session, 34 stocks hit new 52-week lows. Things to Consider About Today's 52-Week Lows: Illumina (NASDAQ:ILMN) was the biggest company...
Via
Benzinga
Buy Smart With Software Stocks on the Dip
January 24, 2022
With tech taking over, software stocks are inevitable winners. But when buying the dip, look for low valuation and high durability.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2022
January 18, 2022
Upgrades Canaccord Genuity upgraded the previous rating for Fortuna Silver Mines Inc (NYSE:
Via
Benzinga
Will Earnings Extend The Rally In Value Stocks?
January 17, 2022
US stocks extended their decline from the first week of 2022. Bank earnings disappointed investors. Inflation remained high. Investors questioned the strength of the economy to get through the omicron...
Via
Talk Markets
10 Health Care Stocks With Whale Alerts In Today's Session
January 12, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our...
Via
Benzinga
If You Invested $1,000 When Illumina Acquired Solexa, Here's How Much You'd Have Now
January 12, 2022
Genome sequencing company Illumina Inc (NASDAQ: ILMN) has transformed its business over the years with a handful of acquisitions and new product launches. An acquisition in 2006...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 12, 2022
January 12, 2022
Upgrades Citigroup upgraded the previous rating for Solo Brands Inc (NYSE:
Via
Benzinga
48 Biggest Movers From Yesterday
January 12, 2022
Gainers Splash Beverage Group, Inc. (NYSE: SBEV) shares jumped 70.6% to close at $1.80 on Tuesday after the company announced it received authorization to sell its TapouT...
Via
Benzinga
Illumina Jumps As Gene Sequencing Demand Drives Stronger Outlook
January 11, 2022
Piper says Pacific Bio has a new competitor in Illumina amid plans to launch what looks like a consumable allowing long-read sequencing on its analyzers.
Via
Talk Markets
30 Stocks Moving In Tuesday's Mid-Day Session
January 11, 2022
Gainers TSR, Inc. (NASDAQ: TSRI) shares climbed 36.6% to $12.21 following Q2 results. The company reported Q2 revenue of $23.9 million, versus $16.1 million year over year....
Via
Benzinga
$100 Invested In This Stock 5 Years Ago, Would Be Worth This Much
January 11, 2022
Illumina (NASDAQ:ILMN) has outperformed the market over the past 5 years by 3.83% on an annualized basis. Buying $100 In ILMN: 5 years ago, an investor could have purchased 0.62...
Via
Benzinga
The Daily Biotech Pulse: Illunina Announces Multiple Partnerships, Immunome Slides On Regulatory Setback For COVID Antibody Drug, Preannouncements Pour In
January 11, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus BioAtla, Bristol-Myers Squibb Announce Collaboration To Evaluate ADC-Opdivo...
Via
Benzinga
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.